Literature DB >> 23869548

Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.

Karthik Arumugam1, Serge Crouzy, Andy Chevigne, Carole Seguin-Devaux, Jean-Claude Schmit.   

Abstract

This article describes the construction and validation of a three-dimensional model of the human CC chemokine receptor 5 (CCR5) receptor using multiple homology modeling. A new methodology is presented where we built each secondary structural model of the protein separately from distantly related homologs of known structure. The reliability of our approach for G-protein coupled receptors was assessed through the building of the human C-X-C chemokine receptor type 4 (CXCR4) receptor of known crystal structure. The models are refined using molecular dynamics simulations and energy minimizations using CHARMM, a classical force field for proteins. Finally, docking models of both the natural agonists and the antagonists of the receptors CCR5 and CXCR4 are proposed. This study explores the possible binding process of ligands to the receptor cavity of chemokine receptors at molecular and atomic levels. We proposed few crucial residues in receptors binding to agonist/antagonist for further validation through experimental analysis. In particular, our study provides better understanding of the blockage mechanism of the chemokine receptors CCR5 and CXCR4, and may help the identification of new lead compounds for drug development in HIV infection, inflammatory diseases, and cancer metastasis.

Entities:  

Keywords:  CCR5; CXCR4; agonist; antagonist; docking; molecular dynamics simulation; pairwise homologs

Mesh:

Substances:

Year:  2013        PMID: 23869548     DOI: 10.1080/07391102.2013.817952

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

Review 1.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

2.  Comparative molecular dynamics simulations of mitogen-activated protein kinase-activated protein kinase 5.

Authors:  Inger Lindin; Yimingjiang Wuxiuer; Aina Westrheim Ravna; Ugo Moens; Ingebrigt Sylte
Journal:  Int J Mol Sci       Date:  2014-03-19       Impact factor: 5.923

3.  Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

Authors:  Vic Arendt; Mathieu Amand; Gilles Iserentant; Morgane Lemaire; Cécile Masquelier; Gilles F Ndayisaba; Chris Verhofstede; Etienne Karita; Susan Allen; Andy Chevigné; Jean-Claude Schmit; Danielle Perez Bercoff; Carole Seguin-Devaux
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

Review 4.  Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.

Authors:  Hager Mohamed; Theodore Gurrola; Rachel Berman; Mackenzie Collins; Ilker K Sariyer; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

5.  The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection.

Authors:  Qingwen Jin; Hong Chen; Xingxia Wang; Liandong Zhao; Qingchen Xu; Huijuan Wang; Guanyu Li; Xiaofan Yang; Hongming Ma; Haoquan Wu; Xiaohui Ji
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.